Tuesday, March 12th  Baltimore, MD – USA

Join us during SOT Annual Meeting in Baltimore MD, USA for our exhibitor hosted session with Citoxlab.

Recent Advances in ECG Analysis for ProArrhythmia Risk Assessment: The Need to Read Between the Lines.

In the last 5 years, FDA has actively characterized innovative ECG analysis methods for proarrhythmia assessments in clinical trials. ECG is a cornerstone of cardiac safety monitoring in toxicology and safety pharmacology with similarities between clinical and non-clinical evaluations.

The session will compare well established ECG analysis methods used in toxicology with novel strategies that may offer lower false positive rates. Critical success factors in the analysis of pre-clinical ECGs will also be discussed.

The ECG’s acquired during this study were collected by easyTEL+ L EEEETA implanted telemetry. 

WHEN:         March 12, 2018  /  12:00 – 13:00
WHERE:       SOT & ToxExpo 2019, Baltimore Convention Center / Meeting Room 337
SPEAKER:    Dr. Simon Authier – Deputy Chief Scientific Officer, Citoxlab North America

Register Now

2019 SOT Annual Meeting & ToxExpo
March 10-14, 2019
Baltimore MD – USA
Booth 4109 & 4111

How to find us?

SOT 2019 floorplan

Other posts you may like

Software solution with SEND compatible outputs

Discover how emka helps you to comply with regulatory guidance

SOT 59th Annual Meeting and ToxExpo

Wednesday March 18th, 2020 Anaheim, CA - USA

Happy Holidays from all of us at emka TECHNOLOGIES

Please take note that our offices will be closed during holidays. Consult the dates here.

Pharmacology 2019

December 15-17, 201 Edinburgh, UK Booth #14